Impact of tyloxapol to combat acute phase response in comparison with betamethasone and flunixin meglumine following an ovine experimentally induced endotoxemia model
Submitted: 12 October 2015
Accepted: 24 November 2015
Published: 19 September 2016
Accepted: 24 November 2015
Abstract Views: 1521
PDF: 435
HTML: 403
HTML: 403
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Supporting Agencies
Heidari, S. M. M., Badiei, K., Chalmeh, A., Pourjafar, M., Rahmani Shahraki, A., Nazifi, S., & Zamiri, M. J. (2016). Impact of tyloxapol to combat acute phase response in comparison with betamethasone and flunixin meglumine following an ovine experimentally induced endotoxemia model. Veterinary Science Development, 6(1). https://doi.org/10.4081/vsd.2016.6251
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.